Immunotherapy Enhances Outcomes for Advanced Hodgkin Lymphoma
Groundbreaking Treatment Boosts Survival Rates for Hodgkin Lymphoma An innovative cancer treatment that supercharges the immune system has significantly improved survival rates for advanced Hodgkin lymphoma, raising the two-year survival rate to a remarkable 92%. Published in the prestigious New England Journal of Medicine, the study heralds a potential new standard of care for the…